Cited in:


This article has been cited by:

  1. 1
    Sonia Bakkour, Daniel M. Chafets, Li Wen, Kent Dupuis, Grace Castro, Jennifer M. Green, Adonis Stassinopoulos, Michael P. Busch, Tzong-Hae Lee, Assessment of nucleic acid modification induced by amotosalen and ultraviolet A light treatment of platelets and plasma using real-time polymerase chain reaction amplification of variable length fragments of mitochondrial DNA, Transfusion, 2016, 56, 1
  2. 2
    Maite Aubry, Vaea Richard, Jennifer Green, Julien Broult, Didier Musso, Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination, Transfusion, 2016, 56, 1
  3. 3
    S. L. Stramer, R. Y. Dodd, C. Y. Chiu, Advances in testing technology to ensure transfusion safety – NAT and beyond, ISBT Science Series, 2015, 10, S1
  4. 4
    Jacques Cinqualbre, Daniel Kientz, Emilie Remy, Norman Huang, Laurence Corash, Jean Pierre Cazenave, Comparative effectiveness of plasma prepared with amotosalen-UVA pathogen inactivation and conventional plasma for support of liver transplantation, Transfusion, 2015, 55, 7
  5. 5
    Steven Kleinman, Pathogen inactivation, Current Opinion in Hematology, 2015, 22, 6, 547


  6. 6
    Steve Kleinman, Adonis Stassinopoulos, Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation, Transfusion, 2015, 55, 12